Lamotrigine
NDC 46708-418, Lamotrigine, tablet, extended release, from Alembic Pharmaceuticals Limited.
- Product NDC
- 46708-418
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211821
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46708-418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46708-418-30 | 46708041830 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-418-30) |
| 46708-418-91 | 46708041891 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-418-91) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/faee013c-cad2-4abb-904c-e6ff79ba778c
Use it
Look up 46708-418 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46708-418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46708-418. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.